Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice
Y Lin, Y Shao, J Yan, G Ye - Journal of Clinical Laboratory …, 2023 - Wiley Online Library
Increasing rates of Helicobacter pylori resistance are associated with multiple clinical
challenges. Bacterial factors linked to H. pylori resistance are mutations, efflux pumps, and …
challenges. Bacterial factors linked to H. pylori resistance are mutations, efflux pumps, and …
Relationships of Proton Pump Inhibitor‐Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study
R Fukui, S Noda, Y Ikeda, Y Sawayama… - Clinical …, 2024 - Wiley Online Library
Proton pump inhibitors (PPIs) have recently been reported to be linked with nephrotoxicity.
PPIs are metabolized mainly or partly by cytochrome P450 2C19 (CYP2C19). However, the …
PPIs are metabolized mainly or partly by cytochrome P450 2C19 (CYP2C19). However, the …
Pharmacokinetics and bioequivalence evaluation of omeprazole and sodium bicarbonate dry suspensions in healthy Chinese volunteers
R Zhang, P Guo, J Zhou, P Li, J Wan, C Yang… - Scientific Reports, 2023 - nature.com
Omeprazole and sodium bicarbonate dry suspension are effective treatments for acid-
related disorders. This study compared the bioequivalence and safety of the two …
related disorders. This study compared the bioequivalence and safety of the two …
Comparative Histomorphological and Histostereological Teratogenic Effects of In-utero Exposure to Varied Doses of Omeprazole and Pantoprazole on Fetal Kidneys …
AN Nyaga - 2024 - ir.jkuat.ac.ke
Omeprazole and pantoprazole are proton pump inhibitor medicines which are commonly
used in management of gastric esophageal reflux disease during pregnancy. However, their …
used in management of gastric esophageal reflux disease during pregnancy. However, their …